Abeona Therapeutics (ABEO) Stock Price, Quote & News

Company Profile

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 813 4701

Website: www.abeonatherapeutics.com

Address:

6555 Carnegie Avenue, 4th Floor, Cleveland, United States

TragicRain Apr. 28 at 10:45 AM

$ABEO - Released the ARS for year end - and for a brand new commercial company - Not bad! Actually made some revenue compared to past years of being negative. All good news pointing forward...... Happy Happy times indeed.....

0 · Reply

creditgoo Apr. 27 at 7:12 PM

$ABEO everyones excited for earnings but it will be a nothing burger

1 · Reply

Po556677 Apr. 27 at 6:37 PM

$ABEO Crooked market makers and shorts will try to push this down before earnings.....dont be alarmed just buy if you can/good things on the way!!!

0 · Reply

jbernard Apr. 27 at 1:53 PM

$ABEO May 14, 2026, premarket

0 · Reply

Po556677 Apr. 27 at 12:57 PM

$ABEO Anyone know when earning are suppose to come out?

0 · Reply

Po556677 Apr. 25 at 3:31 PM

$ABEO WHY does this stock have a 31% short interest????Plenty of cash/no debt/company going to be profitable VERY SOON. Are they crazy???

4 · Reply

Marcel20 Apr. 24 at 9:36 PM

$ABEO BULLISH soon!

1 · Reply

Abelixe Apr. 24 at 5:22 PM

$ABEO

0 · Reply

TragicRain Apr. 24 at 3:42 PM

$ABEO - Listen - dont assume you are of any importance to me or anyone most likely..... I will do as I like......I like goo....I think people like him are funny......If you cancel out everyone that disagrees with you - that makes you the weak one....not them.... Have a Happy weekend....

1 · Reply

JimiJoJeeter Apr. 24 at 3:14 PM

$ABEO Buy buy buy!!!

1 · Reply

Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors

Apr 6, 2026, 8:30 AM EDT - 22 days ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 2, 2026, 8:30 AM EDT - 26 days ago

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

Mar 17, 2026, 8:30 AM EDT - 6 weeks ago

Abeona Therapeutics Earnings Call Transcript: Q4 2025

Mar 17, 2026, 7:30 AM EDT - 6 weeks ago

Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates

Mar 10, 2026, 8:40 AM EDT - 7 weeks ago

Abeona Therapeutics Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 7:30 AM EDT - 7 weeks ago

Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch

Mar 3, 2026, 7:30 AM EST - 2 months ago

Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference

Dec 15, 2025, 7:30 AM EST - 4 months ago

Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer

Dec 11, 2025, 7:30 AM EST - 4 months ago

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas

Dec 8, 2025, 7:30 AM EST - 5 months ago

Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy

Nov 13, 2025, 1:20 PM EST - 5 months ago

Abeona Therapeutics Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 8:30 AM EST - 5 months ago

Abeona Therapeutics Earnings Call Transcript: Q3 2025

Nov 12, 2025, 7:30 AM EST - 5 months ago

Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates

Nov 7, 2025, 7:30 AM EST - 6 months ago

Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation

Oct 30, 2025, 10:45 AM EDT - 6 months ago

Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)

Oct 20, 2025, 8:30 AM EDT - 6 months ago

Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs

Oct 13, 2025, 7:30 AM EDT - 7 months ago

Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program

Oct 8, 2025, 7:30 AM EDT - 7 months ago

Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy

Sep 9, 2025, 2:00 PM EDT - 8 months ago

Abeona Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 10:20 AM EDT - 8 months ago

Abeona Therapeutics Transcript: Cantor Global Healthcare Conference 2025

Aug 29, 2025, 7:30 AM EDT - 8 months ago

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Aug 14, 2025, 7:30 AM EDT - 9 months ago

Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates

Aug 14, 2025, 7:30 AM EDT - 9 months ago

Abeona Therapeutics Earnings Call Transcript: Q2 2025

Jul 29, 2025, 10:00 AM EDT - 9 months ago

AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients

Jul 15, 2025, 7:30 AM EDT - 10 months ago

ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area

Jul 14, 2025, 7:00 AM EDT - 10 months ago

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

TECH

Jul 2, 2025, 7:30 AM EDT - 10 months ago

Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million

Jul 1, 2025, 7:30 AM EDT - 10 months ago

Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy

Jun 30, 2025, 7:30 AM EDT - 10 months ago

Abeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index

Jun 24, 2025, 7:30 AM EDT - 11 months ago

Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa

Jun 4, 2025, 11:40 AM EDT - 11 months ago

Abeona Therapeutics Transcript: Jefferies Global Healthcare Conference 2025

May 30, 2025, 8:46 AM EDT - 11 months ago

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference

May 15, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates

May 15, 2025, 7:00 AM EDT - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q1 2025

May 14, 2025, 8:07 AM EDT - 1 year ago

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

May 14, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

May 14, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder

May 12, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million

Apr 30, 2025, 4:41 PM EDT - 1 year ago

Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease

Apr 29, 2025, 6:06 AM EDT - 1 year ago

US FDA approves Abeona's skin disorder therapy

Apr 29, 2025, 6:00 AM EDT - 1 year ago

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Mar 20, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans

Mar 20, 2025, 7:30 AM EDT - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q4 2024

Mar 10, 2025, 3:00 PM EDT - 1 year ago

Abeona Therapeutics Transcript: Leerink’s Global Healthcare Conference 2025

Mar 4, 2025, 9:00 AM EST - 1 year ago

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference

Nov 18, 2024, 4:10 PM EST - 1 year ago

Abeona Therapeutics Transcript: Stifel 2024 Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

Nov 14, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

Nov 4, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics® Announces Participation in November Investor Conferences

Oct 29, 2024, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

Sep 19, 2024, 9:45 AM EDT - 1 year ago

Abeona Therapeutics Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 10, 2024, 1:30 PM EDT - 1 year ago

Abeona Therapeutics Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors

Aug 13, 2024, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel

Aug 12, 2024, 8:30 AM EDT - 1 year ago

Abeona Therapeutics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 7:30 AM EDT - 1 year ago

Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

Jul 11, 2024, 7:30 AM EDT - 1 year ago

Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications

Jul 9, 2024, 9:45 AM EDT - 1 year ago

Abeona Therapeutics Transcript: Stifel Virtual Cell Therapy Forum

Jul 8, 2024, 7:30 AM EDT - 1 year ago

Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum

Jun 6, 2024, 11:30 AM EDT - 2 years ago

Abeona Therapeutics Transcript: Jefferies Global Healthcare Conference

Jun 3, 2024, 7:30 AM EDT - 2 years ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 28, 2024, 7:30 AM EDT - 2 years ago

Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference

May 15, 2024, 8:30 AM EDT - 2 years ago

Abeona Therapeutics Earnings Call Transcript: Q1 2024

May 15, 2024, 7:30 AM EDT - 2 years ago

Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress

May 3, 2024, 7:30 AM EDT - 2 years ago

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Apr 23, 2024, 8:30 AM EDT - 2 years ago

Abeona Therapeutics Transcript: Status Update

Mar 18, 2024, 9:30 AM EDT - 2 years ago

Abeona Therapeutics Earnings Call Transcript: Q4 2023

Nov 13, 2023, 8:30 AM EST - 2 years ago

Abeona Therapeutics Earnings Call Transcript: Q3 2023

Sep 27, 2023, 9:30 AM EDT - 2 years ago

Abeona Therapeutics Transcript: Jefferies Cell & Genetic Medicine Summit

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Abeona Therapeutics Earnings Call Transcript: Q2 2023

May 24, 2023, 8:30 AM EDT - 3 years ago

Abeona Therapeutics Earnings Call Transcript: Q1 2023

Mar 29, 2023, 8:30 AM EDT - 3 years ago

Abeona Therapeutics Earnings Call Transcript: Q4 2022

Nov 3, 2022, 5:00 AM EDT - 3 years ago

Abeona Therapeutics Transcript: Study Result

Aug 11, 2022, 12:45 PM EDT - 4 years ago

Abeona Therapeutics Earnings Call Transcript: Q2 2022

May 17, 2022, 4:10 AM EDT - 4 years ago

Abeona Therapeutics Earnings Call Transcript: Q1 2022

Nov 16, 2021, 7:00 PM EST - 4 years ago

Abeona Therapeutics Earnings Call Transcript: Q3 2021

Jul 28, 2021, 8:00 PM EDT - 5 years ago

Abeona Therapeutics Earnings Call Transcript: Q2 2021

May 25, 2021, 7:43 AM EDT - 5 years ago

Abeona Therapeutics Earnings Call Transcript: Q1 2021

TragicRain Apr. 28 at 10:45 AM

0 · Reply

creditgoo Apr. 27 at 7:12 PM

$ABEO everyones excited for earnings but it will be a nothing burger

1 · Reply

Po556677 Apr. 27 at 6:37 PM

$ABEO Crooked market makers and shorts will try to push this down before earnings.....dont be alarmed just buy if you can/good things on the way!!!

0 · Reply

jbernard Apr. 27 at 1:53 PM

$ABEO May 14, 2026, premarket

0 · Reply

Po556677 Apr. 27 at 12:57 PM

$ABEO Anyone know when earning are suppose to come out?

0 · Reply

Po556677 Apr. 25 at 3:31 PM

$ABEO WHY does this stock have a 31% short interest????Plenty of cash/no debt/company going to be profitable VERY SOON. Are they crazy???

4 · Reply

Marcel20 Apr. 24 at 9:36 PM

$ABEO BULLISH soon!

1 · Reply

Abelixe Apr. 24 at 5:22 PM

$ABEO

0 · Reply

TragicRain Apr. 24 at 3:42 PM

1 · Reply

JimiJoJeeter Apr. 24 at 3:14 PM

$ABEO Buy buy buy!!!

1 · Reply

Po556677 Apr. 24 at 3:14 PM

$ABEO Stock actually needed this....was over bought on the charts........load for earnings

0 · Reply

creditgoo Apr. 24 at 3:04 PM

$ABEO you guys should not be invested here. The highest it will go is 7. But with all the dilution. 3s first

0 · Reply

FitzCatalyst Apr. 24 at 3:01 PM

$ABEO this stock….

0 · Reply

creditgoo Apr. 24 at 2:47 PM

$ABEO shouldve took those gains above 5.6 bulls. Under 5 again next week

0 · Reply

TragicRain Apr. 24 at 11:11 AM

$ABEO - We still love you .....*Happy Hugs* for you ...

1 · Reply

creditgoo Apr. 23 at 10:26 PM

$ABEO the happy feeling when it all disappears even quicker

0 · Reply

TragicRain Apr. 23 at 12:03 PM

$ABEO - That Happy feeling you get, when the price is inching up, and we move closer to the next update about the company and you believe the news will just continue to be positive especially for a new commercial company product..... Happy times indeed...... @creditgoo We still love you buddy....

1 · Reply

Marcel20 Apr. 22 at 8:23 PM

$ABEO next leg up soon

1 · Reply

Pharma3000 Apr. 22 at 8:05 PM

$ABEO lets see how long it takes to see a short squeeze here🤑

1 · Reply

TragicRain Apr. 22 at 7:52 PM

$ABEO - Happy Happy dance....

0 · Reply

MarketPro Apr. 22 at 7:43 PM

$ABEO Chart Update:

0 · Reply

Marcel20 Apr. 22 at 7:15 PM

$ABEO better get in now. Price targets of the analysts are over 20 $

1 · Reply

Market Cap	306.60M
Revenue (ttm)	5.82M
Net Income (ttm)	71.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	1,223.02%
Debt to Equity Ratio	0.13

Volume	148,949
Avg Vol	1,208,740
Day's Range	N/A - N/A
Shares Out	56.88M
Stochastic %K	50%
Beta	1.22
Analysts	Strong Sell
Price Target	$19.71